Ghiath M. Sukhtian, Director, 10% Owner at Outlook Therapeutics, Inc. (OTLK), bought 8,539,709 shares at $0.59 ($5.0M) on 2026-05-28, disclosed to the SEC on 2026-06-01.
Open-market purchase of $5.0M OTLK by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |